IGC PHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2012
Total Assets: $25.3M
Liabilities Breakdown FY2012
Total Liabilities: $9.4M
Asset Breakdown
Total Assets: $25.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $562.9K | 2.2% |
| Accounts Receivable | $1.6M | 6.5% |
| Inventory | $387.5K | 1.5% |
| Property, Plant & Equipment | $8.5M | 33.6% |
| Goodwill | $965.7K | 3.8% |
| Intangible Assets | $3.8M | 15.2% |
| Other Assets | $9.4M | 37.1% |
Liabilities Breakdown
Total Liabilities: $9.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $337.1K | 3.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $9.1M | 96.4% |